791 related articles for article (PubMed ID: 34068714)
1. Phytochemicals Targeting JAK-STAT Pathways in Inflammatory Bowel Disease: Insights from Animal Models.
Moon SY; Kim KD; Yoo J; Lee JH; Hwangbo C
Molecules; 2021 May; 26(9):. PubMed ID: 34068714
[TBL] [Abstract][Full Text] [Related]
2. Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease.
Coskun M; Salem M; Pedersen J; Nielsen OH
Pharmacol Res; 2013 Oct; 76():1-8. PubMed ID: 23827161
[TBL] [Abstract][Full Text] [Related]
3. Targeting JAK/STAT signaling pathways in treatment of inflammatory bowel disease.
Wang L; Hu Y; Song B; Xiong Y; Wang J; Chen D
Inflamm Res; 2021 Jul; 70(7):753-764. PubMed ID: 34212215
[TBL] [Abstract][Full Text] [Related]
4. Advances in the Development of Janus Kinase Inhibitors in Inflammatory Bowel Disease: Future Prospects.
Flamant M; Rigaill J; Paul S; Roblin X
Drugs; 2017 Jul; 77(10):1057-1068. PubMed ID: 28523588
[TBL] [Abstract][Full Text] [Related]
5. JAK-STAT pathway targeting for the treatment of inflammatory bowel disease.
Salas A; Hernandez-Rocha C; Duijvestein M; Faubion W; McGovern D; Vermeire S; Vetrano S; Vande Casteele N
Nat Rev Gastroenterol Hepatol; 2020 Jun; 17(6):323-337. PubMed ID: 32203403
[TBL] [Abstract][Full Text] [Related]
6. Targeting the JAK/STAT Signaling Pathway Using Phytocompounds for Cancer Prevention and Therapy.
Bose S; Banerjee S; Mondal A; Chakraborty U; Pumarol J; Croley CR; Bishayee A
Cells; 2020 Jun; 9(6):. PubMed ID: 32545187
[TBL] [Abstract][Full Text] [Related]
7. A Review: Phytochemicals Targeting JAK/STAT Signaling and IDO Expression in Cancer.
Arumuggam N; Bhowmick NA; Rupasinghe HP
Phytother Res; 2015 Jun; 29(6):805-17. PubMed ID: 25787773
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of JAK/STAT-signaling in patients with ulcerative colitis and Crohn's disease.
Cordes F; Foell D; Ding JN; Varga G; Bettenworth D
World J Gastroenterol; 2020 Jul; 26(28):4055-4075. PubMed ID: 32821070
[TBL] [Abstract][Full Text] [Related]
9. Targeting JAK-STAT signal transduction in IBD.
Soendergaard C; Bergenheim FH; Bjerrum JT; Nielsen OH
Pharmacol Ther; 2018 Dec; 192():100-111. PubMed ID: 30048708
[TBL] [Abstract][Full Text] [Related]
10. Integrating Immunologic Signaling Networks: The JAK/STAT Pathway in Colitis and Colitis-Associated Cancer.
Zundler S; Neurath MF
Vaccines (Basel); 2016 Feb; 4(1):. PubMed ID: 26938566
[TBL] [Abstract][Full Text] [Related]
11. JAK inhibition in inflammatory bowel disease.
Olivera P; Danese S; Peyrin-Biroulet L
Expert Rev Clin Immunol; 2017 Jul; 13(7):693-703. PubMed ID: 28164724
[TBL] [Abstract][Full Text] [Related]
12. The Future of Janus Kinase Inhibitors in Inflammatory Bowel Disease.
De Vries LCS; Wildenberg ME; De Jonge WJ; D'Haens GR
J Crohns Colitis; 2017 Jul; 11(7):885-893. PubMed ID: 28158411
[TBL] [Abstract][Full Text] [Related]
13.
Hong ZS; Xie J; Wang XF; Dai JJ; Mao JY; Bai YY; Sheng J; Tian Y
Front Immunol; 2022; 13():924178. PubMed ID: 35911761
[TBL] [Abstract][Full Text] [Related]
14. Phytochemicals targeting JAK/STAT pathway in the treatment of rheumatoid arthritis: Is there a future?
Kour G; Choudhary R; Anjum S; Bhagat A; Bajaj BK; Ahmed Z
Biochem Pharmacol; 2022 Mar; 197():114929. PubMed ID: 35065024
[TBL] [Abstract][Full Text] [Related]
15. Leaky gut model of the human intestinal mucosa for testing siRNA-based nanomedicine targeting JAK1.
Hartwig O; Loretz B; Nougarede A; Jary D; Sulpice E; Gidrol X; Navarro F; Lehr CM
J Control Release; 2022 May; 345():646-660. PubMed ID: 35339579
[TBL] [Abstract][Full Text] [Related]
16. Kinase Signaling in Colitis-Associated Colon Cancer and Inflammatory Bowel Disease.
Temby M; Boye TL; Hoang J; Nielsen OH; Gubatan J
Biomolecules; 2023 Nov; 13(11):. PubMed ID: 38002302
[TBL] [Abstract][Full Text] [Related]
17. Potential therapeutic effects of curcumin mediated by JAK/STAT signaling pathway: A review.
Ashrafizadeh M; Rafiei H; Mohammadinejad R; Afshar EG; Farkhondeh T; Samarghandian S
Phytother Res; 2020 Aug; 34(8):1745-1760. PubMed ID: 32157749
[TBL] [Abstract][Full Text] [Related]
18. The Role of JAK/STAT Molecular Pathway in Vascular Remodeling Associated with Pulmonary Hypertension.
Roger I; Milara J; Montero P; Cortijo J
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34067108
[TBL] [Abstract][Full Text] [Related]
19. JAK Inhibition: The Most Promising Agents in the IBD Pipeline?
Fernández-Clotet A; Castro-Poceiro J; Panés J
Curr Pharm Des; 2019; 25(1):32-40. PubMed ID: 30950344
[TBL] [Abstract][Full Text] [Related]
20. JAK inhibition using tofacitinib for inflammatory bowel disease treatment: a hub for multiple inflammatory cytokines.
Danese S; Grisham M; Hodge J; Telliez JB
Am J Physiol Gastrointest Liver Physiol; 2016 Feb; 310(3):G155-62. PubMed ID: 26608188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]